ALEXANDER MARGARET A. 4
4 · Ovid Therapeutics Inc. · Filed Feb 28, 2025
Insider Transaction Report
Form 4
ALEXANDER MARGARET A.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-02-26$0.56/sh−5,279$2,956→ 73,406 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.